Quarterly report [Sections 13 or 15(d)]

Restructuring (Details)

Restructuring (Details) $ in Thousands	3 Months Ended			12 Months Ended
Restructuring (Details) $ in Thousands	Sep. 30, 2026 USD ($)	Jun. 30, 2026 USD ($)	Sep. 30, 2025 USD ($) installment	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)
Restructuring
Recovery of assets held-for-sale			$ 6,789
Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	$ 1,406		125	$ 8,909	$ 95,631
Cash payments	(2,444)			(15,611)
Non-cash adjustments				6,789	(94,530)
Restructuring reserve, end of period	150	$ 1,188		1,188	1,101
Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	$ 2,258	4,231
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling, General and Administrative Expense
Cash payments	$ (3,367)	(2,709)
Restructuring reserve, end of period	413	1,522		1,522
Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	1,406		3,208
Protein Sciences \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	262
Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			(3,823)
Exosome Diagnostics \| Disposed of by Sale \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Stock consideration receivable			5,000
Exosome Diagnostics \| Held for sale
Restructuring
Cumulative impairment charge					83,100
Exosome Diagnostics \| Held for sale \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Goodwill attributable to disposal group held for sale					4,500
Consideration for sale			15,000
Consideration as stock			6,800
Recovery of assets held-for-sale			$ 6,800
No. of installments \| installment			4
Installment amount			$ 2,500
Corporate \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			740
Corporate \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	1,996
Location, Statement of Income, Balance [Axis]: us-gaap:CostOfGoodsAndServicesSold \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			$ 1,482
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]			Cost of Goods and Services Sold
Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			$ (1,357)
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]			Selling, General and Administrative Expense
Employee severance \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			$ 5,342	6,681	1,041
Cash payments	(1,038)			(6,534)
Restructuring reserve, end of period	150	1,188		1,188	1,041
Employee severance \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	262	760
Cash payments	(708)	(314)
Restructuring reserve, end of period		446		446
Employee severance \| Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			1,636
Employee severance \| Protein Sciences \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	262
Employee severance \| Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			2,966
Employee severance \| Corporate \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			740
Asset-related and other \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	1,406		1,572	9,017	11,531
Cash payments	(1,406)			(9,077)
Non-cash adjustments					(11,471)
Restructuring reserve, end of period					60
Asset-related and other \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	1,996	3,471
Cash payments	(2,659)	(2,395)
Restructuring reserve, end of period	413	$ 1,076		1,076
Asset-related and other \| Protein Sciences \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs	1,406		1,572
Asset-related and other \| Corporate \| Fiscal Year 2026 Restructuring Actions
Restructuring
Restructuring costs	$ 1,996
Impairment (Recovery) of assets held-for-sale \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			(6,789)	(6,789)	83,059
Non-cash adjustments				$ 6,789	$ (83,059)
Impairment (Recovery) of assets held-for-sale \| Diagnostics and Spatial Biology \| Restructuring Plan to Optimize Global Manufacturing
Restructuring
Restructuring costs			$ (6,789)